Structure–activity relationships study of 6-chloro-4-(2-chlorophenyl)-3-(2-hydroxyethyl) quinolin-2(1H)-one derivatives as novel non-nucleoside anti-hepatitis B virus agents
- 31 January 2011
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 46 (1) , 307-319
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81025023)
- Xibu Zhiguang Joint-Scholarship of Chinese Academy of Sciences, the External Cooperation Program of Chinese Academy of Sciences (GJHI200818)
- CAS (CAS-CF07/08.SC03)
- –
- Croucher Fund
This publication has 27 references indexed in Scilit:
- Review article: current antiviral therapy of chronic hepatitis BAlimentary Pharmacology & Therapeutics, 2008
- Periglaucines A−D, Anti-HBV and -HIV-1 Alkaloids from Pericampylus glaucusJournal of Natural Products, 2008
- Anti-hepatitis B virus drugs in clinical and preclinical developmentVirologica Sinica, 2008
- Chronic hepatitis B in hepatocarcinogenesisPostgraduate Medical Journal, 2006
- Hepatitis B virus infection: Current statusThe American Journal of Medicine, 2005
- Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measuresJournal of Viral Hepatitis, 2004
- Design and Synthesis of Novel 5-Substituted Acyclic Pyrimidine Nucleosides as Potent and Selective Inhibitors of Hepatitis B VirusJournal of Medicinal Chemistry, 2002
- Strategies to prevent and control hepatitis B and C virus infections: a global perspectiveVaccine, 1999
- Hepatitis B virus (HBV) envelope glycoproteins vary drastically in their sensitivity to glycan processing: Evidence that alteration of a single N-linked glycosylation site can regulate HBV secretionProceedings of the National Academy of Sciences, 1997
- Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis BAnnals of Internal Medicine, 1993